All articles tagged: Schizophrenia (F20)
HealthDay
23 January at 04.13 PM
Severe QT Prolongation Common in Users of Antipsychotic MedicationsMore than one in eight patients receiving quetiapine or haloperidol therapy appear to develop severe QT prolongation (SQTP), according to a study published online Jan. 14 in Heart Rhythm.Chun-Li Wang, M.D., from the Linkou Medical Center in Taoyuan, Taiwan, and colleagues examined the incidences, risk factors, and outcomes of SQTP |
|
HealthDay
16 January at 04.59 AM
Many With Psychosis Have Long-Term Functional MorbidityA diagnosis of psychosis in adolescence is associated with long-term functional morbidity, meeting the criteria for not being in education, employment, and training (NEET), according to a study published online Oct. 28 in Schizophrenia Bulletin.Ida Ringbom, M.D., from the University of Turku in Finland, and colleagues examined risk fact |
Evalytics
18 December at 06.28 PM
Kids with cats have more than double the risk of developing schizophrenia, researchers findA study indicates that childhood exposure to cats may slightly raise the risk of developing schizophrenia later in life. This elevated risk is attributed to potential exposure to the Toxoplasma gondii parasite carried by cats but is only one of several contributing factors to the disorder. |
|
HealthDay
08 December at 04.30 PM
Tardive Dyskinesia Impacts Patients and CaregiversTardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.Rakesh Jain, M.D., M.P.H., from the Texas Tech University School of Medicine-Permian Basin in Midland, and colleagues conducted an online survey to assess pati |
|
HealthDay
06 December at 04.49 PM
Brain Stimulation Can Improve Prospective Memory in SchizophreniaFor patients with schizophrenia, bilateral high-frequency repetitive transcranial magnetic stimulation (rTMS) can improve event-based prospective memory (EBPM), according to a study published online Dec. 6 in Neuropsychopharmacology Reports.Fen Xue, from the Mental Health Hospital in Beijing, and colleagues examined the effects of rTM |
|
HealthDay
30 November at 09.59 PM
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHDThe presence of psychiatric comorbidity in young patients with attention-deficit/hyperactivity disorder (ADHD) is associated with a higher risk for being diagnosed with schizophrenia, according to a study published online Nov. 30 in JAMA Network Open.Soo Min Jeon, Pharm.D., Ph.D., from Jeju National University in South Korea, and |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
|
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
|
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
|
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
